OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) has filed a shelf registration statement on Form S-3 with the US Securities and Exchange ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE